Product Images Ranolazine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ranolazine NDC 69367-294 by Westminster Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - ranolazine 01
PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - ranolazine 02
Each extended-release tablet contains 500 mg of Ranolazine. It is recommended to store the tablets at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to ‘Temperature]. Consult dosage and administration instructions for Ranolazine Extended-Release Tablets. The tablets should be swallowed whole, and one should not crush, break, or chew them. Manufactured by ScleGen Pharmaceuticals, Inc. for Westminster Pharmaceuticals, LLC. NDC 69367-203-60. Rev 05/21.*
PRINCIPAL DISPLAY PANEL - 1000 mg Tablet Bottle Label - ranolazine 03
Each extended-release tablet contains 1000 mg of Ranolazine. It should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). Swallow Ranolazine Extended-Release tablets whole; do not crush, break, or chew. See packaging for dosage and administration. Manufactured by ScieGen Pharmaceuticals, Inc. for Westminster Pharmaceuticals, LLC, Nashville, TN 37217.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.